BioLife Solutions (BLFS)

• Market cap: $1.27B
• 1 day: 4.90%
• 5 days: 2.32%
• 1 month: 9.52%
• 3 months: 6.29%
• 6 months: 31.49%
• Year to date: 71.40%
• 1 year: 79.37%
• 5 years: 76.60%
• 10 years: 1,388.59%
• Sector: Healthcare
• Industry: Electromedical & Electrotherapeutic Apparatus

About: BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

Employees: 414

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

483% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 6

72% more call options, than puts

Call options by funds: $210K | Put options by funds: $122K

18% more funds holding

Funds holding: 164 [Q2] → 193 (+29) [Q3]

13% more capital invested

Capital invested by funds: $1B [Q2] → $1.13B (+$127M) [Q3]

3.85% less ownership

Funds ownership: 101.72% [Q2] → 97.86% (-3.85%) [Q3]

14% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 65

25% less funds holding in top 10

Funds holding in top 10: 4 [Q2] → 3 (-1) [Q3]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $27 1% downside
• Avg. target: $31 12% upside
• High target: $33 20% upside

5 analyst ratings

• positive: 5 100%
• neutral: 0 0%
• negative: 0 0%

Benchmark Robert Wasserman 55% 1-year accuracy 27 / 49 met price target	10% upside $30	Buy Reiterated	19 Dec 2024
Keybanc Paul Knight 25% 1-year accuracy 2 / 8 met price target	20% upside $33	Overweight Maintained	13 Dec 2024
HC Wainwright & Co. Raghuram Selvaraju 39% 1-year accuracy 121 / 308 met price target	1% downside $27	Buy Maintained	18 Nov 2024
TD Cowen Steven Mah 50% 1-year accuracy 3 / 6 met price target	13% upside $31	Buy Maintained	13 Nov 2024
Craig-Hallum Matt Hewitt 52% 1-year accuracy 13 / 25 met price target	17% upside $32	Buy Maintained	13 Nov 2024